User banner image
User avatar
  • admin

Posts

Cross-industry Team Led by IPG Mediabrands, SeenThis and PubMatic Creates Climate Action Marketplace

KINESSO to Lead Activation on Industry-first Green Media Marketplace NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) — IPG Mediabrands, the media and marketing solutions division...

Forskolin Market is Projected to Reach $1.32 Billion, Growing at a CAGR of 8.5% By 2034 | Fact. MR

Organic and Natural Trend Acting as Boon for Forskolin-based Supplement Manufacturers Rockville, MD., July 01, 2024 (GLOBE NEWSWIRE) — As per a newly compiled research...

Men Skin Care Products Market to hit USD 30.5 billion by 2032, says Global Market Insights Inc.

Men skin care products industry is projected to witness a CAGR of 5% during the period 2023-2032. This growth can be attributed to increasing demand...

NeuroStar® Launches Better Me Provider Program Nationwide

The first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry MALVERN, Pa., July 01, 2024...

G1 Therapeutics Added to the Russell 2000® and 3000® Indexes

RESEARCH TRIANGLE PARK, N.C., July 01, 2024 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the Company has...

Spectral AI Joins Russell Microcap® Index

DALLAS, July 01, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical...

Recce Pharmaceuticals Reports Positive Data from Phase I/II Urinary Tract Infection (UTI) / Urosepsis Rapid Infusion Trial of RECCE® 327

Results demonstrate efficacy on bacterial growth in participants injected with RECCE® 327 (R327) at the highest tested dose of 4,000mg No serious adverse events and...

Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations

The Phase 1 study for OV888/GV101 capsule met its objective, demonstrating a favorable safety and tolerability profile with no serious adverse events Secondary endpoint results...

iQIYI Releases Its XR App for Apple Vision Pro

BEIJING, July 1, 2024 /PRNewswire/ — On June 27, iQIYI, a leading online entertainment service in China, announced the launch of its Apple Vision Pro App,...

DAR GLOBAL STRENGTHENS ONGOING RELATIONSHIP WITH THE TRUMP ORGANIZATION BY ANNOUNCING SECOND COLLABORATION AND FUTURE LAUNCH OF TRUMP TOWER JEDDAH, SAUDI ARABIA

DUBAI, UAE, July 1, 2024 /PRNewswire/ — Dar Global, the luxury international real estate developer, and The Trump Organization, renowned for its prestigious properties and...